SEC Form 4 · accession 0001479791-18-000011
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Jan 31, 2018
Accepted (ET)
Feb 2, 2018 · 3:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Jan 31, 2018 | S | 100 | $0.117 | D | 24,482,599 | D | |
| INVO Bioscience Common Stock | Feb 1, 2018 | S | 9,500 | $0.117 | D | 25,473,099 | D | |
| INVO Bioscience Common Stock | Feb 1, 2018 | S | 1,100 | $0.116 | D | 25,471,999 | D | |
| INVO Bioscience Common Stock | Feb 2, 2018 | S | 8,000 | $0.116 | D | 25,463,999 | D |
Table II — derivative securities
No Table II lines on this filing.